Wait and treat: a new approach to DBD donor with stunned heart F. Procaccio, M. Liviero Casartelli, D Simion Neuro Intensive Care Unit University City.

Slides:



Advertisements
Similar presentations
A Comparison of Early Versus Late Initiation of Renal Replacement Therapy in Critically III Patients with Acute Kidney Injury: A Systematic Review and.
Advertisements

Optimising the brain-stem dead donor
The golden hour(s) for severe sepsis and septic shock treatment
Why you do what you do? Nikki Dotson-Lorello RN, BSN, CCRN, CPTC Organ Recovery Coordinator LifeShare Of The Carolina s.
Paediatric Brain Trauma Management: Moving towards evidence based practice Dr. T. Y. M. Lo Consultant Paediatric Intensivist Royal Hospital for Sick Children,
University of Minnesota – School of Nursing Spring Research Day Glycemic Control of Critically Ill Patients Lynn Jensen, RN; Jessica Swearingen, BCPS,
You have the power to Donate Life!. 20 people Every day nearly 20 people will die waiting for a life-saving organ transplant. The national waiting list.
NPPG PICU SIG Study Day Recap Law and Ethics 22nd July 2013 Stephen Morris NPPG Conference - London 8th November 2013.
1 Donate Life An Introduction to Organ and Tissue Donation.
Donate Life An Introduction to Organ and Tissue Donation.
Technical Assistance for Alignment in Organ Donation- EuropeAid/131052/D/SER/TR Ventilator withdrawal in case of DBD refusal Francesco Procaccio ISS –
Severe Sepsis Initial recognition and resuscitation
Prolonged Diabetes Reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates Hering et al, Nature.
Donation After Cardiac Death May 26, 2010 Margie Whittaker, RN MSN.
Organ Donation & Transplantation in Ireland – Changing times Aileen Counihan Transplant Co-ordinator Beaumont Hospital Beaumont Hospital.
Donor Utilization: Making Use of a Precious Resource in Cardiac Transplant Jason W. Smith, MD Assistant Professor of Surgery The University of Washington.
A homo-dimer of annexin V protects against ischemia reperfusion injury in lung transplantation K Hashimoto, H Kim, H Oishi, M Chen, I Iskender, J Sakamoto,
Organ Transplantation. Transplant History Skin grafts – possibly as early as 2 nd century 1 st confirmed skin graft – 16 th century Tissue transplants.
9.PCH.1.2 Summarize the procedures for organ donation, local and state resources, and benefits.
Heart Transplants. Statistics 1000’s die every year waiting for a heart transplant 100,000’s of people diagnosed with heart failure every year Heart Failure.
Transfusion of Blood Product History: 1920:Sodium citrate anticoagulant(10 days storage) 1958: Plastic bag of transfusion 1656: Initial theory and.
ORGAN DONATION By: Aubree Malone. “When you’re not an organ donor when you die, you’re taking a lot of people with you.”
The Role of Coordinators Throughout the European Union Carl-Ludwig Fischer-Fröhlich, Stuttgart, Germany Thank you to the support of support of all coordinators.
Ventricular Diastolic Filling and Function
© ANZOD Registry International Donor Statistics 1997 % of Multiple Organ Donors Donors PMP % Mult. Donors Eurotransplant:Germany, Austria, Belgium, Luxembourg,
An International Case Study of Lung Transplantation
Donor Case Studies Optimal Management Harbor-UCLA Critical Care – Organ Donation Symposium April 12, 2010 Brant Putnam, MD FACS Trauma / Acute Care Surgery.
Presenter Disclosure Information John F. Beshai, MD RethinQ Trial Results Disclosures Information: The following relationships exist related to this presentation:
Organ Donation. Over 106,000 Americans are on transplant waiting lists (4,500 in NJ) In 1988, 4,080 people donated organs after death. In 2008, that number.
Target Study Cardiac resynchronization therapy (CRT) is an established treatment for advanced heart failure symptoms, impaired LV systolic function, and.
“Rationale for establishing donor management goals.” Cindy Jacobs, RN, BSN, CPTC Professional Development Director.
 Exemplary Care  Cutting-edge Research  World-class Education  Raghavan Murugan MD, MS, FRCP Associate Professor Dept. of Critical Care Medicine Clinical.
Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCOCABG Trial.
ARMYDA-4 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study Prospective, multicenter, randomized, double blind trial investigating.
Kidney Disorders. Kidney Transplant Many consider this to be the best method of treating kidney disease. A transplant may offer the best chance.
A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit The SAFE Study Investigators N Engl J Med 2004: 350:
ITU Journal Club: Dr. Clinton Jones. ST4 Anaesthetics.
Sept 25,  Pulmonary HTN is defined as mean pulmonary artery pressure of > 25 mm Hg (as seen on echo)  Causes of Pulmonary HTN include: PE, COPD,
Donation after Cardiac Death Supporting Patients and Families during End of Life Care in the Operating Room Douglas T Miller Symposium Breakout Session.
Top Papers in Critical Care 2013 Janna Landsperger RN, MSN, ACNP-BC.
Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function R3 김동연 /Prof. 정경환 N Engl J Med 373;5 July 30, 2015.
A pilot randomized controlled trial Registry #: NCT
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Improving Outcomes in DCD Renal Transplantation Reference: Hoogland ERP, Snoeijs MGJ, van Heurn LWE. DCD kidney transplantation: Results and measures to.
Primary Mitral Regurgitation Degenerative Mitral Valve Disease
Prognosis of Patients With LV Dysfunction and CAD
Graft Dysfunction after Heart Transplantation
University of Pennsylvania Philadelphia
Management of a Brain dead donor until retrieval of organs
ST MARGARET OF SCOTLAND HOSPICE
Revascularization in Patients With Left Ventricular Dysfunction:
Enterprise | Interest Nothing to disclose.
C. Chalklin, C. Colmont, A. Zaidi, J. Warden-Smith, E. Ablorsu
Takotsubo Cardiomyopathy (broken heart syndrome) Domina Petric, MD
A, Breakdown of frailty into its underlying causes, manifestations, and clinical outcomes separated by LVAD-responsive and LVAD-independent causes of frailty.
Organ Procurement from Deceased Donors in Kuwait
The Organ Donation Process
REVERSE TAKOTSUBO CARDIOMYOPATHY IN AN ELDERLY PATIENT WITH BACTEREMIA
One Legacy Organ Donation
Patient Presentation Patient’s Changing Condition Multiple Considerations To Balance.
Diastolic heart failure
Left ventricular dilatation, the presence of intra-cardiac thrombus and short term outcome for primary heart graft failure patients managed with ECMO.
INOVATE-HF Trial design: Patients with heart failure (HF) were randomized to device implant for vagus nerve stimulation (n = 436) versus optimal medical.
The Heart Failure Team Heart Failure Care Map First 24 hours.
The Organ Donation Process
Cultivating Relationships with Hospitals to Increase
The incidence of all cause graft failure, and death with a functioning graft was higher in patients who received a DCD donor transplant with total donor.
Nikole J. Byrne et al. BTS 2017;j.jacbts
Midlands Organ Donation Services Team
The Need for Serial Troponin Testing absolute cTn elevations are seen in multiple chronic cardiac and noncardiac conditions rise or fall !! in serial.
Presentation transcript:

Wait and treat: a new approach to DBD donor with stunned heart F. Procaccio, M. Liviero Casartelli, D Simion Neuro Intensive Care Unit University City Hospital Verona - Italy

Rush and retrieve after BD More Time is less Function for the graft “Classical” approach to (unstable) donors to (unstable) donors

Why in DBD donors the functionality of organs is often severely decresed ? These organs are considered not suitable and not utilized.

Myocytolisis Contraction band lesions Inflammation The Adrenergic Storm Catecholamine induced cardiac injury normal Reversible ! Echocardiographic dysfunction in 42% BD Dujardin et al. J Heart Lung Transplant, 2001

Verona protocol 2010 Verona protocol 2010 Key points: Fluid Volume wise Replacement Fluid Volume wise Replacement Cathecolamines sparing strategy by Early Primary HT: T3 - V - Insuline - Methylprednisolone Cathecolamines sparing strategy by Early Primary HT: T3 - V - Insuline - Methylprednisolone Serial Echo + Troponine + PCT Serial Echo + Troponine + PCT Prospective clinical study

52Baseline+ 4 hr Echo 19/52 initial sub-normal 53% improved Hormonal Therapy Did not affect LV function.

Extimated EF 35%; trop 0,2Extimated EF 56%; trop 0,2 Brain Death 48 hours HT ECHOCARDIOGRAPHIC PATTERNS -2 Woman 46 years old, trauma, heart donor  heart transplanted and well working heart transplanted and well working Verona Neuro ICU, Simion et al., 2010

MAP CI SVR HT HT HT HT Taniguchi, 1992

PHDSexAge Early LVEF % Final LVEF % Peak Troponin ng/mL Final Troponin ng/mL MhMh T3 h NE hOutcomeHeartDonor Other Organs 1 M3260 0,470, Donor Yes2L-2K-Li 2 F5460 3,270, Donor Yes2K 3 F , Donor Altered CGF 2K-Li 4 M5155 0,990, Donor Altered CGF 2K-Li 5 M ,700, O pposition -- 6 M Donor Yes2L-2K-Li-P 7 F ,230,214890Donor Yes2K-Li 8 F5660 5,610, Donor Yes2K 9 M ,350, O pposition M ,900, O pposition F , Donor Yes2L-2K-Li 12 F ,800, TBC F ,380, Donor Yes2K 14 M ,320,304230Malignancy F ,402, Donor Yes2K-Li 15 Heart potential Donors out of 27 BD Organ Potential Donors Neuro ICU – Verona 2010 Hours of treatment after BD

HeartRecovering Storm Harvesting Days 1 HT

... no rush but rather an improved donor management prior to retrieval prior to retrieval will benefit donor kidney viability.

Brain Death is a severe illness for the organs but reversible and treatable in ICU

Treating organs in the Donor before harvesting (and out of the Donor before trasplantation) (ex vivo) can improve function in Recipients. Treat and Wait Treating organs in the Donor before harvesting (and out of the Donor before trasplantation) (ex vivo) can improve function in Recipients. …… to be proved by evidence

Can we wait and facilitate organ recovery? To prevent the early graft failure …… to be proved by evidence Treat and Wait